Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: InDi Hires Bencich and Tonachio


Integrated Diagnostics has appointed John Bencich as chief financial officer and Jill Tonachio as vice president for sales.

Bencich most recently served as the CFO of Allozyne. Prior to that, he was vice president, chief financial officer, and treasurer of Trubion Pharmaceuticals until its acquisition by Emergent BioSolutions. Before that he was the director of finance and corporate controller for Onyx Software. He holds a BA in accountancy from the University of San Diego and an MBA from Seattle University.

Tonachio was most recently national director of sales for Aurora Diagnostics. She has also held sales positions at Aureon Laboratories, Laboratory Corporation of America, Dianon Systems, and Johnson & Johnson. She holds a BS in business logistics from Pennsylvania State University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.